Arterial wave reflection in HIV-infected and HIV-uninfected rwandan women

AIDS Research and Human Retroviruses

Volumn 25, Issue 9, 2009, Pages 877-882

  Lazar, Jason M ^a   Wu, Xi ^b   Shi, Qiuhu ^c   Kagame, Abel ^d   Cohen, Mardge ^e   Binagwaho, Agnes ^f   Munyakazi, Louis ^g   Salciccioli, Louis ^a   Shi, Di ^h   Anastos, Kathryn ⁱ  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Analytic Solutions LLC   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d Central Hospital of Kigali   (Rwanda)

^e Department of Ambulatory and Community Health   (United States)

^f Rwanda National AIDS Control Commission   (Rwanda)

^g National Institute of Statistics   (Rwanda)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERIAL PRESSURE; ARTERIAL WAVE REFLECTION; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; FEMALE; HEART RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RADIAL ARTERY; TONOMETRY;

ADULT; ARTERIES; ATHEROSCLEROSIS; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PULSE; RWANDA;

EID: 70349285247     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0269     Document Type: Article

References (34)

1. Friis-Moller N, Weber R, Reiss P, et al.: Cardiovascular disease risk factors in HIV patients-association with anti-retroviral therapy. Results from the DAD study. AIDS 2003;23:17(8)1179-1193.
2. Friis-Moller N, Sabin CA, Weber R, et al.: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349(21):1993- 2003.
3. Mooser V: Atherosclerosis and HIV in the highly active antiretroviral therapy era: Towards an epidemic of cardiovascular disease? AIDS 2003;17(S):65-69.
4. Vittecoq D, Escaut L, Chironi G, et al.: Coronary heart disease in HIV infected patients in the highly active anti-retroviral treatment era. AIDS 2003;17(S):70-76.
5. Van Bortel LM, Duprez D, Starmans-Kool MJ, et al.: Clinical applications of arterial stiffness, Task Force III: Recommendations for user procedures. Am J Hypertens 2002;15(5):445-452.
6. McVeigh GE, Hamilton PK, and Morgan DR: Evaluation of mechanical arterial properties: Clinical, experimental and therapeutic aspects. Clin Sci 2002;102(1):51-67.
7. Syeda B, Gottsauner-Wolf M, Denk S, Pichler P, Khorsand A, and Gloqar D: Arterial compliance: A diagnostic marker for atherosclerotic plaque burden? Am J Hypertens 2003;16:356-362.
8. McVeigh GE, Morgan DJ, Finkelstein SM, Lemay LA, and Cohn JN: Vascular abnormalities associated with long-term cigarette smoking identified by arterial waveform analysis. Am J Med 1997;102:227-231.
9. Resnick LM, Militianu D, Cunnings AJ, et al.: Pulse waveform analysis of arterial compliance: Relation to other techniques, age, and metabolic variables. Am J Hypertens 2000; 13:1243-1249.
10. Mahmud A and Feely J: Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003; 41(1):183-187.
11. Ravikumar R, Deepa R, Shanthirani C, and Mohan V: Augmentation index is associated with cardiovascular risk. J Hypertens 2002;20:2407-2414.
12. Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002;39:10-15.
13. London GM and Cohn JN: Prognostic application of arterial stiffness: Task Forces. Am J Hypertens 2002;15(8):754-758.
14. Chen CH, Nevo E, Fetics B, et al.: Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: Validation of generalized transfer function. Circulation 1997;95:1827-1836.
15. O'Rourke MF and Gallagher DE: Pulse wave analysis. J Hypertens 1996;14:147-157.
16. Wilkinson IB, Fuchs SA, Jansen IM, et al.: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998;16(12 Pt 2):2079-2084.
17. Siebenhofer A, Kemp CRW, Sutton AJ, and Williams B: The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphyg-mocardiography. J Hum Hypertens 1999;13:625-629.
18. Quiros-Roldan E, Torti C, Tinelli C, et al.: Risk factors for myocardial infarction in HIV-positive patients. Int J STD AIDS 2005;16(1):14-18.
19. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, and Blanche S: Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 2004;18(7):1037-1041.
20. Sevastianova K, Sutinen J, Westerbacka J, Ristola M, and Yki-Jarvinen H: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy. Antivir Ther 2005;10(8):925-935.
21. Boccara F, Simon T, Lacombe K, et al.: Influence of pravas-tatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy. AIDS 2006;20(18):2395-2398.
22. Ostrowski SR, Gerstoft J, Pedersen BK, and Ullum H: Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients. AIDS 2003;17(4):521-530.
23. Zhou X, Nicoletti A, Elhage R, and Hansson GK: Transfer of CD4(+) T cells aggravates atherosclerosis in immunode-ficient apolipoprotein E knockout mice. Circulation 2000; 102(24):2919-2922.
24. Lau B, Sharrett AR, Kingsley LA, et al.: C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med 2006;166(1):64-70.
25. Ghaffari S: Detection and management of coronary artery disease in patients with rheumatologic disorders. Rheum Dis Clin North Am 1999;(3):657-668.
26. Van Doornum S, McColl G, and Wicks IP: Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) 2005;44(11):1428-1432.
27. Otedo AE, Oyoo GO, Obondi JO, and Otieno CF: Vasculitis in HIV: Report of eight cases. East Afr Med J 2005;82(12):656-659.
28. Joshi VV, Pawel B, Conner E, Sharer L, Oleske JM, and Morrison S: Arteriopathy in children with AIDS. Pediatr Pathol 1987;7:261-275.
29. Blacher J, Asmar R, Djane S, London GM, and Safar ME: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;33:1111-1117.
30. Vyas M, Izzo JL Jr, Lacourciere Y, et al.: Augmentation index and central aortic stiffness in middle-aged to elderly individuals. Am J Hypertens 2007;20(6):642-647.
31. Sugawara J, Komine H, Hayashi K, Magda S, and Matsuda M: Relationship between augmentation index obtained from carotid and radial artery pressure waveforms. J Hypertens 2007;25(2):375-381.
32. Yasmin and Brown MJ: Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM 1999;92(10):595-600.
33. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, and Webb DJ: The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000;525:263-267.
34. McEniery CM, Yasmin, Hall IR, et al.: Normal vascular aging: Differential effects on wave reflection and aortic pulse wave velocity: The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46(9):1753-1760.